ID    AVR/I/SSAP412
ET    Non-clinical
PN    Lysostaphin
PL    13 [Note: any special compound, if present in sequence, is not considered in length]
SR    Not available
SO    Staphylococcus simulans
TX    Bacteria
VL    Experimentally validated
XX
TO    VISA 5827
IC    log10 CFU/ML = 9.85(0.06)
TH    Lysostaphin alone showed no haemolysis or effect on Vero cell viability, and when combined with ranalexin, did not increase toxicity beyond ranalexin alone, with toxic concentrations for erythrocytes and Vero cells exceeding those needed for antibacterial efficacy in human serum.
XR    RCSB PDB/PDBsum/PDBe/PDBj/PDBe-KB/MMDB: Not available 
XR    UniProt: Not available
XR    DrugBank: Not available
XX
SQ    SEQUENCE  
      Not availa ble 
//

